179 related articles for article (PubMed ID: 10870044)
1. Cyclin D and cyclin E expression in normal and adenomatous pituitary.
Jordan S; Lidhar K; Korbonits M; Lowe DG; Grossman AB
Eur J Endocrinol; 2000 Jul; 143(1):R1-6. PubMed ID: 10870044
[TBL] [Abstract][Full Text] [Related]
2. Expression analysis of cyclins in pituitary adenomas and the normal pituitary gland.
Turner HE; Nagy Z; Sullivan N; Esiri MM; Wass JA
Clin Endocrinol (Oxf); 2000 Sep; 53(3):337-44. PubMed ID: 10971451
[TBL] [Abstract][Full Text] [Related]
3. Galanin in human pituitary adenomas: frequency and clinical significance.
Leung B; Iisma TP; Leung KC; Hort YJ; Turner J; Sheehy JP; Ho KK
Clin Endocrinol (Oxf); 2002 Mar; 56(3):397-403. PubMed ID: 11940053
[TBL] [Abstract][Full Text] [Related]
4. Low expression of the cell cycle inhibitor p27Kip1 in normal corticotroph cells, corticotroph tumors, and malignant pituitary tumors.
Lidhar K; Korbonits M; Jordan S; Khalimova Z; Kaltsas G; Lu X; Clayton RN; Jenkins PJ; Monson JP; Besser GM; Lowe DG; Grossman AB
J Clin Endocrinol Metab; 1999 Oct; 84(10):3823-30. PubMed ID: 10523037
[TBL] [Abstract][Full Text] [Related]
5. Mutation and expression analysis of the p27/kip1 gene in corticotrophin-secreting tumours.
Dahia PL; Aguiar RC; Honegger J; Fahlbush R; Jordan S; Lowe DG; Lu X; Clayton RN; Besser GM; Grossman AB
Oncogene; 1998 Jan; 16(1):69-76. PubMed ID: 9467944
[TBL] [Abstract][Full Text] [Related]
6. Reduced expression of the growth hormone and type 1 insulin-like growth factor receptors in human somatotroph tumours and an analysis of possible mutations of the growth hormone receptor.
Kola B; Korbonits M; Diaz-Cano S; Kaltsas G; Morris DG; Jordan S; Metherell L; Powell M; Czirják S; Arnaldi G; Bustin S; Boscaro M; Mantero F; Grossman AB
Clin Endocrinol (Oxf); 2003 Sep; 59(3):328-38. PubMed ID: 12919156
[TBL] [Abstract][Full Text] [Related]
7. Differential expression of cyclin D1 in human pituitary tumors: relation to MIB-1 and p27/Kip1 labeling indices.
Hewedi IH; Osman WM; El Mahdy MM
J Egypt Natl Canc Inst; 2011 Dec; 23(4):171-9. PubMed ID: 22776845
[TBL] [Abstract][Full Text] [Related]
8. Cell cycle dysregulation in pituitary oncogenesis.
Muşat M; Vax VV; Borboli N; Gueorguiev M; Bonner S; Korbonits M; Grossman AB
Front Horm Res; 2004; 32():34-62. PubMed ID: 15281339
[TBL] [Abstract][Full Text] [Related]
9. Growth hormone and prolactin responses to corticotrophin-releasing-hormone in patients with Cushing's disease: a paracrine action of the adenomatous corticotrophic cells?
Loli P; Boccardi E; Branca V; Bramerio M; Barberis M; Losa M; Terreni MT; Lodrini S; Pollo B; Vignati F
Clin Endocrinol (Oxf); 1998 Oct; 49(4):433-9. PubMed ID: 9876339
[TBL] [Abstract][Full Text] [Related]
10. Human TRH receptor messenger ribonucleic acid levels in normal and adenomatous pituitary: analysis by the competitive reverse transcription polymerase chain reaction method.
Kaji H; Xu Y; Takahashi Y; Abe H; Tamaki N; Chihara K
Clin Endocrinol (Oxf); 1995 Mar; 42(3):243-8. PubMed ID: 7758228
[TBL] [Abstract][Full Text] [Related]
11. Demonstration of activin in normal pituitary and in various human pituitary adenomas by immunohistochemistry.
Demura R; Kubo O; Suzuki T; Yajima R; Tajima S; Takakura K; Demura H; Aiba M; Eto Y
Endocr J; 1996 Aug; 43(4):429-32. PubMed ID: 8930532
[TBL] [Abstract][Full Text] [Related]
12. Expression patterns of cyclins D1, E and cyclin-dependent kinase inhibitors p21(Waf1/Cip1) and p27(Kip1) in urothelial carcinoma: correlation with other cell-cycle-related proteins (Rb, p53, Ki-67 and PCNA) and clinicopathological features.
Ioachim E; Michael M; Stavropoulos NE; Kitsiou E; Hastazeris K; Salmas M; Stefanaki S; Agnantis NJ
Urol Int; 2004; 73(1):65-73. PubMed ID: 15263796
[TBL] [Abstract][Full Text] [Related]
13. Localization of vascular endothelial growth factor (VEGF) receptors in normal and adenomatous pituitaries: detection of a non-endothelial function of VEGF in pituitary tumours.
Onofri C; Theodoropoulou M; Losa M; Uhl E; Lange M; Arzt E; Stalla GK; Renner U
J Endocrinol; 2006 Oct; 191(1):249-61. PubMed ID: 17065408
[TBL] [Abstract][Full Text] [Related]
14. Non-functioning pituitary adenomas with positive immunoreactivity for ACTH behave more aggressively than ACTH immunonegative tumours but do not recur more frequently.
Bradley KJ; Wass JA; Turner HE
Clin Endocrinol (Oxf); 2003 Jan; 58(1):59-64. PubMed ID: 12519413
[TBL] [Abstract][Full Text] [Related]
15. Biochemical assessment of Cushing's disease in patients with corticotroph macroadenomas.
Katznelson L; Bogan JS; Trob JR; Schoenfeld DA; Hedley-Whyte ET; Hsu DW; Zervas NT; Swearingen B; Sleeper M; Klibanski A
J Clin Endocrinol Metab; 1998 May; 83(5):1619-23. PubMed ID: 9589666
[TBL] [Abstract][Full Text] [Related]
16. Expression of D-type cyclins in normal and neoplastic rat pituitary.
Qian X; Kulig E; Jin L; Lloyd RV
Endocrinology; 1998 Apr; 139(4):2058-67. PubMed ID: 9528994
[TBL] [Abstract][Full Text] [Related]
17. Macrophage migration inhibitory factor expression is increased in pituitary adenoma cell nuclei.
Pyle ME; Korbonits M; Gueorguiev M; Jordan S; Kola B; Morris DG; Meinhardt A; Powell MP; Claret FX; Zhang Q; Metz C; Bucala R; Grossman AB
J Endocrinol; 2003 Jan; 176(1):103-10. PubMed ID: 12525254
[TBL] [Abstract][Full Text] [Related]
18. Glycoprotein hormone alpha-subunit production and plurihormonality in human corticotroph tumours--an in vitro and immunohistochemical study.
Desai B; Burrin JM; Nott CA; Geddes JF; Lamb EJ; Aylwin SJ; Wood DF; Thakkar C; Monson JP
Eur J Endocrinol; 1995 Jul; 133(1):25-32. PubMed ID: 7542980
[TBL] [Abstract][Full Text] [Related]
19. Expression of epidermal growth factor receptor in neoplastic pituitary cells: evidence for a role in corticotropinoma cells.
Theodoropoulou M; Arzberger T; Gruebler Y; Jaffrain-Rea ML; Schlegel J; Schaaf L; Petrangeli E; Losa M; Stalla GK; Pagotto U
J Endocrinol; 2004 Nov; 183(2):385-94. PubMed ID: 15531726
[TBL] [Abstract][Full Text] [Related]
20. Cyclins D1 and D3 and topoisomerase II alpha in inactive pituitary adenomas.
Saeger W; Schreiber S; Lüdecke DK
Endocr Pathol; 2001; 12(1):39-47. PubMed ID: 11478267
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
